Aaron Wealth Advisors
VRTX icon

Aaron Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Aaron Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.64M Buy
5,048
+27
+0.5% +$13.8K 0.13% 100
2026
Q2 		$2.49M Sell
5,021
-21
-0.4% -$9.31K 0.13% 103
2026
Q1 		$2.25M Buy
5,042
+117
+2% +$54.6K 0.13% 98
2025
Q4 		$2.23M Buy
4,925
+1,003
+26% +$432K 0.12% 112
2025
Q3 		$1.54M Buy
3,922
+703
+22% +$294K 0.09% 154
2025
Q2 		$1.43M Sell
3,219
-88
-3% -$40.6K 0.15% 97
2025
Q1 		$1.6M Buy
3,307
+193
+6% +$89.9K 0.18% 76
2024
Q4 		$1.25M Sell
3,114
-72
-2% -$33.4K 0.15% 92
2024
Q3 		$1.48M Buy
3,186
+245
+8% +$118K 0.18% 81
2024
Q2 		$1.38M Buy
2,941
+245
+9% +$106K 0.19% 72
2024
Q1 		$1.13M Buy
2,696
+139
+5% +$58.8K 0.16% 82
2023
Q4 		$1.04M Buy
2,557
+61
+2% +$22.5K 0.17% 74
2023
Q3 		$868K Buy
2,496
+15
+0.6% +$5.25K 0.11% 95
2023
Q2 		$873K Buy
2,481
+40
+2% +$13.5K 0.11% 100
2023
Q1 		$769K Buy
2,441
+260
+12% +$78K 0.11% 108
2022
Q4 		$630K Sell
2,181
-198
-8% -$60.3K 0.09% 129
2022
Q3 		$689K Buy
2,379
+47
+2% +$13.5K 0.13% 93
2022
Q2 		$657K Buy
2,332
+66
+3% +$17.7K 0.17% 81
2022
Q1 		$591K Sell
2,266
-25
-1% -$5.93K 0.14% 94
2021
Q4 		$503K Buy
+2,291
New +$445K 0.14% 97

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
AMF Tjänstepension
AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Montrusco Bolton Investments
Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return
Birch Hill Investment Advisors
Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Provident Investment Management
Provident Investment Management Novi, Michigan $999M AUM 19.45% 1-Year Est. Return

Aaron Wealth Advisors's VRTX Position: Q3 2026 in Review

Aaron Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 0.54% in Q3 2026, buying an estimated $13.8K and bringing the position to 5,048 shares worth $2.64M. The position accounts for 0.13% of the portfolio, ranked #100.

Aaron Wealth Advisors first reported a position in VRTX in Q4 2021 and has held it in 20 quarters since. 478 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Aaron Wealth Advisors held 5,048 shares of Vertex Pharmaceuticals worth $2.64M as of Q3 2026.
  • Aaron Wealth Advisors bought 27 Vertex Pharmaceuticals shares in Q3 2026, an estimated $13.8K.
  • Vertex Pharmaceuticals made up 0.13% of Aaron Wealth Advisors's portfolio in Q3 2026, its #100 holding.
  • Aaron Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 20 quarters since.
  • 478 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Aaron Wealth Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.